Industry Insights & News 2018-02-01T19:10:58+00:00

Industry Insights & News

DTx Industry Insights

The Digital Therapeutics industry emerged from the broader digital health category, and has quickly differentiated itself via companies’ clinical fidelity, evidence-based approaches, policy engagement, and commitment to outcome-focused reimbursement.

Take This App and Call Me in the Morning

New York Times (Natasha Singer) -- Health tech companies are making a big push to digitize medicine, introducing novel tools like digital pills that track when patients take their drugs and smart spoons that can automatically [...]

Digital therapeutics: Preparing for takeoff

McKinsey & Company -- Digital therapeutics have made much progress over the past decade, harnessing technology to supplement or potentially replace traditional clinical therapy. Some devices complement traditional treatment by helping patients manage their condition, [...]

A New Sort of Health App Can Do the Job of Drugs

The Economist -- Luann Stottlemyer has had diabetes for 23 years, but it was only in 2016 that her doctor prescribed a treatment that changed her life. It has allowed her to bring her blood-sugar [...]

A Revolution In Health Care Is Coming

The Economist -- This week three of the biggest names in American business—Amazon, Berkshire Hathaway and JPMorgan Chase—announced a new venture to provide better, cheaper health care for their employees. A fundamental problem with today’s [...]

Load More Posts

DTA Press Releases & Statements

Our Alliance is dedicated to advancing novel platforms and solutions that improve patients’ lives and add value to physicians, care teams, and the healthcare system.

Digital Therapeutics Alliance and USP Announce Collaboration

WASHINGTON, June 4, 2018 /PRNewswire-USNewswire/ – The Digital Therapeutics Alliance (DTA) and USP announced a collaboration to explore the development of appropriate standards and guidelines for digital therapeutics at a roundtable discussion co-hosted by the [...]

The Digital Therapeutics Alliance Announces New Members

Arlington, VA — May 8, 2018 — The Digital Therapeutics Alliance welcomes nine companies to membership: Bayer, Big Health, Cognoa, Kaia Health, Merck, Omada Health, Otsuka America Pharmaceutical, Inc., Pear Therapeutics, and Sanofi. “Digital medicine has the [...]

Load More Posts

DTx Research & Studies

Digital Therapeutic companies are committed to collecting real word data, assessing ongoing safety and effectiveness, and ensuring that DTx product integrity and clinical efficacy is maintained by the continual generation, analysis, and sharing of clinical data in peer-reviewed journals.

Load More Posts

Stay Up To Date


Sign Up Now